Exact Mass: 616.374

12-O-Tetradecanoylphorbol-13-acetate

C36H56O8 (616.3975)

12-o-tetradecanoylphorbol-13-acetate appears as white crystals. (NTP, 1992) Phorbol 13-acetate 12-myristate is a phorbol ester that is phorbol in which the hydroxy groups at the cyclopropane ring juction (position 13) and the adjacent carbon (position 12) have been converted into the corresponding acetate and myristate esters. It is a major active constituent of the seed oil of Croton tiglium. It has been used as a tumour promoting agent for skin carcinogenesis in rodents and is associated with increased cell proliferation of malignant cells. However its function is controversial since a decrease in cell proliferation has also been observed in several cancer cell types. It has a role as a protein kinase C agonist, an antineoplastic agent, a reactive oxygen species generator, a plant metabolite, a mitogen, a carcinogenic agent and an apoptosis inducer. It is an acetate ester, a tetradecanoate ester, a diester, a tertiary alpha-hydroxy ketone and a phorbol ester. Phorbol 12-myristate 13-acetate diester is an inducer of neutrophil extracellular traps (NETs). Phorbol 12-myristate 13-acetate is a natural product found in Iris tectorum, Phormidium tenue, and other organisms with data available. Tetradecanoylphorbol Acetate is a phorbol ester with potential antineoplastic effects. Tetradecanoylphorbol acetate (TPA) induces maturation and differentiation of hematopoietic cell lines, including leukemic cells. This agent may induce gene expression and protein kinase C (PKC) activity. In addition to potential antineoplastic effects, TPA may exhibit tumor promoting activity. (NCI04) A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA. A phorbol ester that is phorbol in which the hydroxy groups at the cyclopropane ring juction (position 13) and the adjacent carbon (position 12) have been converted into the corresponding acetate and myristate esters. It is a major active constituent of the seed oil of Croton tiglium. It has been used as a tumour promoting agent for skin carcinogenesis in rodents and is associated with increased cell proliferation of malignant cells. However its function is controversial since a decrease in cell proliferation has also been observed in several cancer cell types. C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D009676 - Noxae > D002273 - Carcinogens > D010703 - Phorbol Esters Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Phorbol 12-myristate 13-acetate (PMA), a phorbol ester, is a dual SphK and protein kinase C (PKC) activator[1][2]. Phorbol 12-myristate 13-acetate is a NF-κB activator. Phorbol 12-myristate 13-acetate induces differentiation in THP-1 cells[3][7]. Phorbol 12-myristate 13-acetate (PMA), a phorbol ester, is a dual SphK and protein kinase C (PKC) activator[1][2]. Phorbol 12-myristate 13-acetate is a NF-κB activator. Phorbol 12-myristate 13-acetate induces differentiation in THP-1 cells[3][7].

Calebassine

C40H48N4O2+2 (616.3777)

Tabernamine

C40H48N4O2 (616.3777)

Avermectin A2a aglycone

C35H52O9 (616.3611)

Crassostrea Secocarotenoid

C40H56O5 (616.4128)

Crassostrea Secocarotenoid is found in mollusks. Crassostrea Secocarotenoid is a constituent of the oyster Crassostrea gigas. Constituent of the oyster Crassostrea gigas. Crassostrea Secocarotenoid is found in mollusks.

(3S,3'S,5R,5'R,6R)-6,7-Didehydro-5,6-dihydro-3,3',5,8'-tetrahydroxy-beta,kappa-caroten-6'-one

C40H56O5 (616.4128)

(3S,3S,5R,5R,6R)-6,7-Didehydro-5,6-dihydro-3,3,5,8-tetrahydroxy-beta,kappa-caroten-6-one is found in mollusks. (3S,3S,5R,5R,6R)-6,7-Didehydro-5,6-dihydro-3,3,5,8-tetrahydroxy-beta,kappa-caroten-6-one is a constituent of the oyster Crassostrea gigas. Constituent of the oyster Crassostrea gigas. (3S,3S,5R,5R,6R)-6,7-Didehydro-5,6-dihydro-3,3,5,8-tetrahydroxy-beta,kappa-caroten-6-one is found in mollusks.

Goshonoside F6

C31H52O12 (616.3459)

Goshonoside F6 is found in fruits. Goshonoside F6 is a constituent of Rubus foliolosus (Ceylon raspberry). Constituent of Rubus foliolosus (Ceylon raspberry). Goshonoside F6 is found in fruits.

Nonoxynol-9

C33H60O10 (616.4186)

Nonoxynol-9 (N-9) is a typical surfactant used as a vaginal spermicide. Spermicides are locally acting non-hormonal contraceptives. When present in the vagina during intercourse, they immobilize/inactivate/damage and/or kill sperms without eliciting systemic effects. N-9 has been in use for more than 30 years as an over-the-counter (OTC) drug in creams, gels, foams and condom lubricants. It is the most commonly used spermicidal contraceptive in the UK and the USA. In several European countries, spermicides are no longer on the market. D009676 - Noxae > D000988 - Antispermatogenic Agents > D013089 - Spermatocidal Agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials

(3S,3'S,5R,5'R,6R)-3,6-Epoxy-5,6-dihydro-3',5,8'-trihydroxy-beta,kappa-caroten-6'-one

C40H56O5 (616.4128)

(3S,3S,5R,5R,6R)-3,6-Epoxy-5,6-dihydro-3,5,8-trihydroxy-beta,kappa-caroten-6-one is found in mollusks. (3S,3S,5R,5R,6R)-3,6-Epoxy-5,6-dihydro-3,5,8-trihydroxy-beta,kappa-caroten-6-one is a constituent of the oyster Crassostrea gigas. Constituent of the oyster Crassostrea gigas. (3S,3S,5R,5R,6R)-3,6-Epoxy-5,6-dihydro-3,5,8-trihydroxy-beta,kappa-caroten-6-one is found in mollusks.

PA(16:1(9Z)/14:1(9Z))

C33H61O8P (616.4104)

PA(16:1(9Z)/14:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:1(9Z)/14:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-12:0/18:2(9Z,11Z))

C33H61O8P (616.4104)

PA(i-12:0/18:2(9Z,11Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/18:2(9Z,11Z)), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of (9Z,11Z)-octadecadienoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

13-O-Tetradecanoylphorbol 12-acetate

C36H56O8 (616.3975)

Phorbol 12-myristate 13-acetate

C36H56O8 (616.3975)

D009676 - Noxae > D002273 - Carcinogens > D010703 - Phorbol Esters

17-Dimethylaminogeldanamycin

C32H48N4O8 (616.3472)

Fucoxanthinol

C40H56O5 (616.4128)

PA(8:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C31H53O10P (616.3376)

PA(8:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Leukotriene B4 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/8:0)

C31H53O10P (616.3376)

PA(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/8:0), in particular, consists of one chain of one Leukotriene B4 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C31H53O10P (616.3376)

PA(8:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 5(S),15(S)-Dihydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/8:0)

C31H53O10P (616.3376)

PA(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/8:0), in particular, consists of one chain of one 5(S),15(S)-Dihydroxyeicosatetraenoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C31H53O10P (616.3376)

PA(8:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 5,6-Dihydroxyeicosatetraenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/8:0)

C31H53O10P (616.3376)

PA(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/8:0), in particular, consists of one chain of one 5,6-Dihydroxyeicosatetraenoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Cimicidanol 3-arabinoside

C35H52O9 (616.3611)

Cimigenol-3-O-β-D-xylpyranoside

C35H52O9 (616.3611)

Norpleiomutine

C40H48N4O2 (616.3777)

Amphidinolide F

C35H52O9 (616.3611)

Isogarcinol 13-O-methyl ether

C39H52O6 (616.3764)

Noralpindenoside A

C31H52O12 (616.3459)

Cimicidanol 3-O-alpha-L-arabinoside

C35H52O9 (616.3611)

Chondramide C

C35H44N4O6 (616.3261)

A chondramide formally obtained from N-[(2S,4E,6R,7R)-7-hydroxy-2,4,6-trimethyloct-4-enoyl]-L-alanyl-Nalpha-methyl-D-tryptophanyl-beta-R-beta-tyrosine by intramolecular condensation of the alcoholic hydroxy group with the carboxy group of the beta-tyrosine residue. It is produced by strains of the myxobacterium, Chondromyces crocatus.

6-Formyl-2,3,3a,4,5,8,9,11a-octahydro-10-(hydroxymethyl)-3-methylene-4-(2-methyl-1-oxobutoxy)-2-oxocyclodeca[b]furan-5-yl ester hexadecanoic acid

C36H56O8 (616.3975)

Podocarpaside G

C35H52O9 (616.3611)

Wikstroelide N

C35H52O9 (616.3611)

Picfeltarraenin VI

C35H52O9 (616.3611)

3,4,3,8-Tetrahydroxy-beta,kappa-caroten-6-one

C40H56O5 (616.4128)

Sugikurojin J

C40H56O5 (616.4128)

Cussovantoside C

C31H52O12 (616.3459)

Garcinol 13-O-methyl ether

C39H52O6 (616.3764)

Colossolactone VI

C35H52O9 (616.3611)

Vaucheriaxanthin

C40H56O5 (616.4128)

Paucivenine

C40H48N4O2 (616.3777)

Cussoside C

C31H52O12 (616.3459)

Cussoside D

C31H52O12 (616.3459)

Isofucoxanthinol

C40H56O5 (616.4128)

Cyclomytiloxanthin

C40H56O5 (616.4128)

Fucoxanthinol

C40H56O5 (616.4128)

D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

( )-Kopsoffine

C40H48N4O2 (616.3777)

Goshonoside-F6

C31H52O12 (616.3459)

Boussingoside A1

C35H52O9 (616.3611)

Phycocyanobilin dimethyl ester

C35H44N4O6 (616.3261)

C36H56O8

C36H56O8 (616.3975)

Kopsoffine

C40H48N4O2 (616.3777)

3-(7-ethyl-1,2-didehydro-20,21-dinor-aspidospermidin-16-yl)-vobasan-17-oic acid methyl ester|Capuvosidine

C40H48N4O2 (616.3777)

3beta-(beta-D-glucosyloxy)-16alpha,23alpha-epoxycucurbita-5,24-dien-11-one

C36H56O8 (616.3975)

pfaffoside F

C35H52O9 (616.3611)

Pfaffoside G

C35H52O9 (616.3611)

3-(14,15-dihydro-eburnamenin-14-yl)-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester|Paucivenine

C40H48N4O2 (616.3777)

Crytomeria acetal B

C40H56O5 (616.4128)

spinosyn alpha

C35H52O9 (616.3611)

Phorbol-12-butyrate-13-laurate

C36H56O8 (616.3975)

7beta-(beta-glucopyranosyloxy)-3beta-hydroxycucurbita-5,23,25-trien-19-al|kuguaglycoside C

C36H56O8 (616.3975)

ent-14-labden-8beta,19-diol 13alpha-O-[beta-D-quinovopyranosyl-(1->2)-alpha-L-rhamnopyranoside]

C32H56O11 (616.3822)

pouogenin B

C36H56O8 (616.3975)

A natural product found in Lipastrotethya species.

3beta-hydroxycucurbita-5,24(E)-diene-11-one-26-al-3-O-beta-D-glucopyranoside|hemslepenside A

C36H56O8 (616.3975)

3-oxo-5alpha-lanosta-8,24-dien-21-oic acid ester beta-D-glucoside|ganosinoside A

C36H56O8 (616.3975)

lanost-5-en-3beta-D-glucopyranosyl-21(24)-olide

C36H56O8 (616.3975)

3-O-(beta-D-xylopyranosyl)-22,25-oxidoholothurinogenin

C35H52O9 (616.3611)

Cabin-3|VVSVLT

C28H52N6O9 (616.3796)

ent-14-labden-8beta-ol 13alpha-O-alpha-L-rhamnopyranosyl-19-O-alpha-L-rhamnopyranoside

C32H56O11 (616.3822)

21-desethyl-21-cyclobutyl spinosyn A 17-pseudoaglycone

C35H52O9 (616.3611)

Pentadecadienoic acid

C35H52O9 (616.3611)

(3S,4R)-3,4-dihydroxy-3,6-epoxy-1,2,5,6,7,8-hexahydro-6-methyl-16-nor-beta,phi-carotene-1,8-dione|3,4-Dihydroxy-3,6-epoxy-1,2,5,67,8-hexahydro-6-methyl-16-nor-??,搂脗-carotene-1,8-dione

C40H56O5 (616.4128)

(5R,7R,8R,9R,10S,11R,13S,17S)-17-{(2R,3S,5R)-5-[(1R)-1,2-dihydroxy-2-methylpropyl]-2-methoxytetrahydrofuran-3-yl}-4,5,6,7,8,9,10,11,12,13,16,17-dodechydro-4,4,8,10,13-pentamethyl-3-oxo-3H-cyclopenta[a]phenanthrene-7,11-diyl diacetate|protoxylocarpin E

C35H52O9 (616.3611)

Coscinastreroside E

C32H56O11 (616.3822)

ent-14-labden-3beta,8beta-diol 13alpha-O-[beta-D-quinovopyranosyl-(1->2)-alpha-L-rhamnopyranoside]

C32H56O11 (616.3822)

C40H56O5

C40H56O5 (616.4128)

saponin A

C36H56O8 (616.3975)

12beta-Hydroxycarbomethoxyacetyl-quercinsaeure-methylester

C36H56O8 (616.3975)

13-O-decanoyl-20-O-hexanoylingenol

C36H56O8 (616.3975)

C39H52O6

C39H52O6 (616.3764)

Kuguaglycoside C

C36H56O8 (616.3975)

Kuguaglycoside C is a natural product found in Momordica charantia with data available.

Cimicifugoside H1

C35H52O9 (616.3611)

Cimicifugoside H1 is a natural product found in Actaea elata, Actaea cimicifuga, and other organisms with data available. See also: Black Cohosh (part of).

Phorbol 12-myristate 13-acetate

C36H56O8 (616.3975)

Phorbol 12-myristate 13-acetate (PMA), a phorbol ester, is a dual SphK and protein kinase C (PKC) activator[1][2]. Phorbol 12-myristate 13-acetate is a NF-κB activator. Phorbol 12-myristate 13-acetate induces differentiation in THP-1 cells[3][7]. Phorbol 12-myristate 13-acetate (PMA), a phorbol ester, is a dual SphK and protein kinase C (PKC) activator[1][2]. Phorbol 12-myristate 13-acetate is a NF-κB activator. Phorbol 12-myristate 13-acetate induces differentiation in THP-1 cells[3][7].

Ile Ile Trp Trp

C34H44N6O5 (616.3373)

Ile Leu Trp Trp

C34H44N6O5 (616.3373)

Ile Trp Ile Trp

C34H44N6O5 (616.3373)

Ile Trp Leu Trp

C34H44N6O5 (616.3373)

Ile Trp Trp Ile

C34H44N6O5 (616.3373)

Ile Trp Trp Leu

C34H44N6O5 (616.3373)

Lys Lys Arg Trp

C29H48N10O5 (616.3809)

Lys Lys Trp Arg

C29H48N10O5 (616.3809)

Lys Gln Arg Trp

C28H44N10O6 (616.3445)

Lys Gln Trp Arg

C28H44N10O6 (616.3445)

Lys Arg Lys Trp

C29H48N10O5 (616.3809)

Lys Arg Gln Trp

C28H44N10O6 (616.3445)

Lys Arg Trp Lys

C29H48N10O5 (616.3809)

Lys Arg Trp Gln

C28H44N10O6 (616.3445)

Lys Trp Lys Arg

C29H48N10O5 (616.3809)

Lys Trp Gln Arg

C28H44N10O6 (616.3445)

Lys Trp Arg Lys

C29H48N10O5 (616.3809)

Lys Trp Arg Gln

C28H44N10O6 (616.3445)

Leu Ile Trp Trp

C34H44N6O5 (616.3373)

Leu Leu Trp Trp

C34H44N6O5 (616.3373)

Leu Trp Ile Trp

C34H44N6O5 (616.3373)

Leu Trp Leu Trp

C34H44N6O5 (616.3373)

Leu Trp Trp Ile

C34H44N6O5 (616.3373)

Leu Trp Trp Leu

C34H44N6O5 (616.3373)

Gln Lys Arg Trp

C28H44N10O6 (616.3445)

Gln Lys Trp Arg

C28H44N10O6 (616.3445)

Gln Arg Lys Trp

C28H44N10O6 (616.3445)

Gln Arg Trp Lys

C28H44N10O6 (616.3445)

Gln Trp Lys Arg

C28H44N10O6 (616.3445)

Gln Trp Arg Lys

C28H44N10O6 (616.3445)

Arg Lys Lys Trp

C29H48N10O5 (616.3809)

Arg Lys Gln Trp

C28H44N10O6 (616.3445)

Arg Lys Trp Lys

C29H48N10O5 (616.3809)

Arg Lys Trp Gln

C28H44N10O6 (616.3445)

Arg Gln Lys Trp

C28H44N10O6 (616.3445)

Arg Gln Trp Lys

C28H44N10O6 (616.3445)

Arg Trp Lys Lys

C29H48N10O5 (616.3809)

Arg Trp Lys Gln

C28H44N10O6 (616.3445)

Arg Trp Gln Lys

C28H44N10O6 (616.3445)

Trp Ile Ile Trp

C34H44N6O5 (616.3373)

Trp Ile Leu Trp

C34H44N6O5 (616.3373)

Trp Ile Trp Ile

C34H44N6O5 (616.3373)

Trp Ile Trp Leu

C34H44N6O5 (616.3373)

Trp Lys Lys Arg

C29H48N10O5 (616.3809)

Trp Lys Gln Arg

C28H44N10O6 (616.3445)

Trp Lys Arg Lys

C29H48N10O5 (616.3809)

Trp Lys Arg Gln

C28H44N10O6 (616.3445)

Trp Leu Ile Trp

C34H44N6O5 (616.3373)

Trp Leu Leu Trp

C34H44N6O5 (616.3373)

Trp Leu Trp Ile

C34H44N6O5 (616.3373)

Trp Leu Trp Leu

C34H44N6O5 (616.3373)

Trp Gln Lys Arg

C28H44N10O6 (616.3445)

Trp Gln Arg Lys

C28H44N10O6 (616.3445)

Trp Arg Lys Lys

C29H48N10O5 (616.3809)

Trp Arg Lys Gln

C28H44N10O6 (616.3445)

Trp Arg Gln Lys

C28H44N10O6 (616.3445)

Trp Trp Ile Ile

C34H44N6O5 (616.3373)

Trp Trp Ile Leu

C34H44N6O5 (616.3373)

Trp Trp Leu Ile

C34H44N6O5 (616.3373)

Trp Trp Leu Leu

C34H44N6O5 (616.3373)

6-Hydroxysiphonaxanthin

C40H56O5 (616.4128)

nonoxynol-9

C33H60O10 (616.4186)

4α-TPA

C36H56O8 (616.3975)

PA(12:0/18:2(9Z,12Z))

C33H61O8P (616.4104)

PA(13:0/17:2(9Z,12Z))

C33H61O8P (616.4104)

PA(14:1(9Z)/16:1(9Z))

C33H61O8P (616.4104)

PA(15:1(9Z)/15:1(9Z))

C33H61O8P (616.4104)

PA(16:1(9Z)/14:1(9Z))

C33H61O8P (616.4104)

PA(17:2(9Z,12Z)/13:0)

C33H61O8P (616.4104)

PA(18:2(9Z,12Z)/12:0)

C33H61O8P (616.4104)

Crassostrea Secocarotenoid

C40H56O5 (616.4128)

(3S,3'S,5R,5'R,6R)-3,6-Epoxy-5,6-dihydro-3',5,8'-trihydroxy-beta,kappa-caroten-6'-one

C40H56O5 (616.4128)

(3S,3'S,5R,5'R,6R)-6,7-Didehydro-5,6-dihydro-3,3',5,8'-tetrahydroxy-beta,kappa-caroten-6'-one

C40H56O5 (616.4128)

Goshonoside F6

C31H52O12 (616.3459)

PA 30:2

C33H61O8P (616.4104)

(3R,5R,6S,3R,5R,6S)-3,6-Epoxy-5-hydroxy-1,2,5,6,7,8-hexahydro-16-nor-beta,psi-carotene-1,8-dione

C40H56O5 (616.4128)

(3R,3R,5S)-3,3,5,19-tetrahydroxy-7,8-didehydro-gamma,epsilon-carotene-8-one

C40H56O5 (616.4128)

19-Hydroxymytiloxanthin

C39H52O6 (616.3764)

(3S,5R,6S,3S,5R)-3,6-Epoxy-5,3,8-triihydroxy-beta,kappa-caroten-6-one

C40H56O5 (616.4128)

Allenicmytiloxanthin

C40H56O5 (616.4128)

butyl 2-methylprop-2-enoate,2-ethylhexyl prop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid,styrene

C36H56O8 (616.3975)

Alvespimycin

C32H48N4O8 (616.3472)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

Pergascript Red I 6B

C42H52N2O2 (616.4029)

Cyclocrassostreaxanthin A

C40H56O5 (616.4128)

1-Myristoyl-2-palmitoleoyl phosphatidate

C33H61O8P-2 (616.4104)

17-Dimethylaminogeldanamycin

C32H48N4O8 (616.3472)

Fucoxanthinol, (all-trans)-

C40H56O5 (616.4128)

PA(8:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C31H53O10P (616.3376)

PA(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/8:0)

C31H53O10P (616.3376)

PA(8:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C31H53O10P (616.3376)

PA(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/8:0)

C31H53O10P (616.3376)

PA(8:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C31H53O10P (616.3376)

PA(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/8:0)

C31H53O10P (616.3376)

(2Z,5E,7E,9E,11E,13E,15E,17Z)-19-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene)-1-(4-hydroxy-1,2,2-trimethylcyclopentyl)-4,8,13,17-tetramethyl-1-oxononadeca-2,5,7,9,11,13,15,17-octaen-3-olate

C40H56O5 (616.4128)

1-Oleoyl-2-lauroyl-sn-glycero-3-phosphate(2-)

C33H61O8P-2 (616.4104)

N-[[(3R,9S,10R)-16-benzamido-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H44N4O6 (616.3261)

N-[(3R,9S,10S)-9-[[benzoyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H44N4O6 (616.3261)

Protoxylocarpin E

C35H52O9 (616.3611)

A natural product found in Xylocarpus granatum.

Ile-Leu-Trp-Trp

C34H44N6O5 (616.3373)

A tetrapeptide composed of L-isoleucine, L-leucine and two L-tryptophan units joined in sequence by peptide linkages.

4,4,4-trifluoro-N-[[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

N-[[(3R,9S,10S)-16-benzamido-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H44N4O6 (616.3261)

4-(dimethylamino)-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide

C36H48N4O5 (616.3625)

N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

N-[(3S,9S,10R)-9-[[benzoyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H44N4O6 (616.3261)

4,4,4-trifluoro-N-[[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

N-[(3S,9R,10R)-9-[[benzoyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H44N4O6 (616.3261)

N-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

N-[[(3S,9R,10R)-16-benzamido-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H44N4O6 (616.3261)

N-[(3S,9R,10R)-9-[[benzoyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H44N4O6 (616.3261)

N-[(3S,9R,10S)-9-[[benzoyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H44N4O6 (616.3261)

N-[(3R,9S,10S)-9-[[benzoyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H44N4O6 (616.3261)

N-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

N-[(3R,9R,10R)-9-[[benzoyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H44N4O6 (616.3261)

N-[[(3S,9S,10R)-16-benzamido-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H44N4O6 (616.3261)

4,4,4-trifluoro-N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

N-[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

4,4,4-trifluoro-N-[[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

4-(dimethylamino)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide

C36H48N4O5 (616.3625)

N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

4,4,4-trifluoro-N-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

4-(dimethylamino)-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide

C36H48N4O5 (616.3625)

N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

4,4,4-trifluoro-N-[[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

N-[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

4,4,4-trifluoro-N-[[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C36H48N4O5 (616.3625)

4,4,4-trifluoro-N-[[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

4,4,4-trifluoro-N-[[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C30H47F3N4O6 (616.3448)

(3S,3S,5R,5R,6R)-6,7-Didehydro-5,6-dihydro-3,3,5,8-tetrahydroxy-beta,kappa-caroten-6-one

C40H56O5 (616.4128)

NAGlySer 20:5/10:0

C35H56N2O7 (616.4087)

NAGlySer 18:5/12:0

C35H56N2O7 (616.4087)

NAGlySer 16:4/14:1

C35H56N2O7 (616.4087)

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoate

C32H57O9P (616.374)

PE-Cer 18:3;2O/12:0;O

C32H61N2O7P (616.4216)

PE-Cer 14:3;2O/16:0;O

C32H61N2O7P (616.4216)

PE-Cer 12:2;2O/18:1;O

C32H61N2O7P (616.4216)

PE-Cer 18:2;2O/12:1;O

C32H61N2O7P (616.4216)

PE-Cer 15:2;2O/15:1;O

C32H61N2O7P (616.4216)

PE-Cer 17:3;2O/13:0;O

C32H61N2O7P (616.4216)

PE-Cer 12:1;2O/18:2;O

C32H61N2O7P (616.4216)

PE-Cer 15:3;2O/15:0;O

C32H61N2O7P (616.4216)

PE-Cer 17:2;2O/13:1;O

C32H61N2O7P (616.4216)

PE-Cer 16:2;2O/14:1;O

C32H61N2O7P (616.4216)

PE-Cer 14:1;2O/16:2;O

C32H61N2O7P (616.4216)

PE-Cer 16:3;2O/14:0;O

C32H61N2O7P (616.4216)

PE-Cer 14:2;2O/16:1;O

C32H61N2O7P (616.4216)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propan-2-yl] decanoate

C32H57O9P (616.374)

[1-decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C32H57O9P (616.374)

PMeOH 14:1_15:1

C33H61O8P (616.4104)

PEtOH 12:0_16:2

C33H61O8P (616.4104)

PMeOH 13:1_16:1

C33H61O8P (616.4104)

PEtOH 13:1_15:1

C33H61O8P (616.4104)

PMeOH 12:0_17:2

C33H61O8P (616.4104)

PEtOH 14:1_14:1

C33H61O8P (616.4104)

PMeOH 13:0_16:2

C33H61O8P (616.4104)

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-icos-11-enoate

C33H60O10 (616.4186)

[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-docos-13-enoate

C33H60O10 (616.4186)

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-nonadec-9-enoate

C33H60O10 (616.4186)

[1-nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-pentadec-9-enoate

C33H60O10 (616.4186)

[1-octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C33H60O10 (616.4186)

[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-octadec-9-enoate

C33H60O10 (616.4186)

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-henicos-11-enoate

C33H60O10 (616.4186)

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-heptadec-9-enoate

C33H60O10 (616.4186)

[1-decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C33H60O10 (616.4186)

[1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] (Z)-tridec-9-enoate

C33H60O10 (616.4186)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C31H53O10P (616.3376)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C31H53O10P (616.3376)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C31H53O10P (616.3376)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C31H53O10P (616.3376)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C31H53O10P (616.3376)

(1-butanoyloxy-3-phosphonooxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate

C33H61O8P (616.4104)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C31H53O10P (616.3376)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C31H53O10P (616.3376)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C31H53O10P (616.3376)

(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

C33H61O8P (616.4104)

(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate

C33H61O8P (616.4104)

(1-octanoyloxy-3-phosphonooxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate

C33H61O8P (616.4104)

[1-phosphonooxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C33H61O8P (616.4104)

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C33H61O8P (616.4104)

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C33H61O8P (616.4104)

[2-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] (Z)-pentadec-9-enoate

C33H61O8P (616.4104)

[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-heptadec-9-enoate

C33H61O8P (616.4104)

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C33H61O8P (616.4104)

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C33H61O8P (616.4104)

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

C33H61O8P (616.4104)

CID 137628422

C40H48N4O2 (616.3777)

(3E,5E,7E,9E,11E,13E,15E,17E)-1-[(2S,3R,5R)-2,3-dimethyl-5-(2-oxopropyl)oxolan-2-yl]-18-[(1S,2S,4R)-2-hydroxy-2,6,6-trimethyl-7-oxabicyclo[2.2.1]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C36H58NO7+ (616.4213)

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (E)-hexadec-9-enoate

C33H61O8P (616.4104)

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (E)-hexadec-7-enoate

C33H61O8P (616.4104)

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (E)-hexadec-7-enoate

C33H61O8P (616.4104)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (11E,14E)-icosa-11,14-dienoate

C33H61O8P (616.4104)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (9E,12E)-heptadeca-9,12-dienoate

C33H61O8P (616.4104)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (5E,8E)-icosa-5,8-dienoate

C33H61O8P (616.4104)

[(2S)-2-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (E)-tetradec-9-enoate

C33H60O10 (616.4186)

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C36H58NO7+ (616.4213)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (6E,9E)-octadeca-6,9-dienoate

C33H61O8P (616.4104)

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C36H58NO7+ (616.4213)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

C33H61O8P (616.4104)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (9E,12E)-octadeca-9,12-dienoate

C33H61O8P (616.4104)

[(2S)-1-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (E)-tetradec-9-enoate

C33H60O10 (616.4186)

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C36H58NO7+ (616.4213)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (9E,11E)-octadeca-9,11-dienoate

C33H61O8P (616.4104)

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C36H58NO7+ (616.4213)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (6E,9E)-octadeca-6,9-dienoate

C33H61O8P (616.4104)

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] (E)-pentadec-9-enoate

C33H61O8P (616.4104)

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (E)-hexadec-9-enoate

C33H61O8P (616.4104)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (5E,8E)-icosa-5,8-dienoate

C33H61O8P (616.4104)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (9E,11E)-octadeca-9,11-dienoate

C33H61O8P (616.4104)

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C36H58NO7+ (616.4213)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (2E,4E)-octadeca-2,4-dienoate

C33H61O8P (616.4104)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate

C33H61O8P (616.4104)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (11E,14E)-icosa-11,14-dienoate

C33H61O8P (616.4104)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (2E,4E)-octadeca-2,4-dienoate

C33H61O8P (616.4104)

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (4E,7E)-hexadeca-4,7-dienoate

C33H61O8P (616.4104)

[3-[3-butanoyloxy-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C36H58NO7+ (616.4213)

2-[[3-acetyloxy-2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H59NO8P+ (616.3978)

2-[[3-hexanoyloxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H59NO8P+ (616.3978)

2-[[3-butanoyloxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H59NO8P+ (616.3978)

2-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-octanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H59NO8P+ (616.3978)

2-[carboxy-[3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]oxy-2-hydroxypropoxy]methoxy]ethyl-trimethylazanium

C36H58NO7+ (616.4213)

Calebassone

C40H48N4O2 (616.3777)

Nonoxynol 9

C33H60O10 (616.4186)

D009676 - Noxae > D000988 - Antispermatogenic Agents > D013089 - Spermatocidal Agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials

Phorbol myristate acetate

C36H56O8 (616.3975)

D009676 - Noxae > D002273 - Carcinogens > D010703 - Phorbol Esters

1-(9Z-hexadecenoyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C33H61O8P (616.4104)

(3S,3S,5R,5R,6R)-3,6-Epoxy-5,6-dihydro-3,5,8-trihydroxy-beta,kappa-caroten-6-one

C40H56O5 (616.4128)

1-Oleoyl-2-lauroyl-sn-glycero-3-phosphate(2-)

C33H61O8P (616.4104)

A 1,2-diacyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-oleoyl-2-lauroyl-sn-glycero-3-phosphate.

BisMePA(28:2)

C33H61O8P (616.4104)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

MGDG 10:0_14:1

C33H60O10 (616.4186)

MGDG 24:1

C33H60O10 (616.4186)

MGDG O-24:2;O

C33H60O10 (616.4186)

DGGA 22:2;O

C31H52O12 (616.3459)

DGGA 23:1

C32H56O11 (616.3822)

MGGA 24:1

C33H60O10 (616.4186)

PA O-16:0/13:4;O2

C32H57O9P (616.374)

PA O-18:0/12:3;O

C33H61O8P (616.4104)

PA O-20:0/9:4;O2

C32H57O9P (616.374)

PA O-28:5;O3

C31H53O10P (616.3376)

PA O-29:4;O2

C32H57O9P (616.374)

PA O-30:3;O

C33H61O8P (616.4104)

PA P-16:0/13:3;O2

C32H57O9P (616.374)

PA P-16:1/12:3;O3

C31H53O10P (616.3376)

PA P-20:1/8:3;O3

C31H53O10P (616.3376)

PA 16:0/13:3;O

C32H57O9P (616.374)

PA 16:1/12:3;O2

C31H53O10P (616.3376)

PA 18:1/11:2;O

C32H57O9P (616.374)

PA 20:1/8:3;O2

C31H53O10P (616.3376)

PA 20:2/8:2;O2

C31H53O10P (616.3376)

PA 20:2/9:1;O

C32H57O9P (616.374)

PA 20:3/8:1;O2

C31H53O10P (616.3376)

PA 22:0/7:3;O

C32H57O9P (616.374)

PA 28:4;O2

C31H53O10P (616.3376)

PA 29:3;O

C32H57O9P (616.374)

PA 10:0_20:2

C33H61O8P (616.4104)

PA 12:0_18:2

C33H61O8P (616.4104)

PA 13:0_17:2

C33H61O8P (616.4104)

PA 14:1_16:1

C33H61O8P (616.4104)

PA 15:1/15:1

C33H61O8P (616.4104)

PA 26:1/4:1

C33H61O8P (616.4104)

PA 26:2/4:0

C33H61O8P (616.4104)

LPG 26:4

C32H57O9P (616.374)

PG O-10:0/16:4

C32H57O9P (616.374)

PG O-25:5;O

C31H53O10P (616.3376)

PG P-18:1/7:3;O

C31H53O10P (616.3376)

PEth 27:3;O

C32H57O9P (616.374)

PEth 28:2

C33H61O8P (616.4104)

PM 28:3;O

C32H57O9P (616.374)

PM 29:2

C33H61O8P (616.4104)

6'-Hydroxysiphonaxanthin

C40H56O5 (616.4128)

Hydroxysiphonaxanthin

C40H56O5 (616.4128)

ST 25:0;O6;GlcA

C31H52O12 (616.3459)

ST 29:4;O3;GlcA

C35H52O9 (616.3611)

ST 25:1;O7;Hex

C31H52O12 (616.3459)

ST 26:0;O6;Hex

C32H56O11 (616.3822)

ST 29:5;O4;Hex

C35H52O9 (616.3611)

Cimicifugoside H-1

C35H52O9 (616.3611)

Cimicifugoside H-1, a cyclolanostanol xyloside, is a major constituent of C. foetida L. extract. Cimicifugoside H-1 inhibits bone resorption and ovariectomy-induced bone loss[1][2][3]. Cimicifugoside H-1, a cyclolanostanol xyloside, is a major constituent of C. foetida L. extract. Cimicifugoside H-1 inhibits bone resorption and ovariectomy-induced bone loss[1][2][3].

(2z,4e,6e,8e,10e,12e,14e,16e)-19-[(2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-3-hydroxy-1-[(1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl]-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

(2r,3r,4s,5s,6r)-2-{[(1s,2r,4as,5r,8as)-2-hydroxy-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methoxy}-6-({[(2r,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxane-3,4,5-triol

C31H52O12 (616.3459)

(1r,2s,4r,5s,6s,10s,11r,12r,14r,15r)-5,6,11,15-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-14-yl (2e,4e)-pentadeca-2,4-dienoate

C35H52O9 (616.3611)

methyl (1s,9s,16s,18s,21r)-6-[(15r,17s,19r)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate

C40H48N4O2 (616.3777)

(2z,4e,6e,8e,10e,12e,14e,16e,18e)-19-[(3r,4s)-3,4-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3-hydroxy-1-[(1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl]-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

7-[(hexanoyloxy)methyl]-5,6,12-trihydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-4-yl decanoate

C36H56O8 (616.3975)

(2r,3s,4s,5r,6r)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[(1r,4s,5s,9r,10r,13s,14r)-14-hydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methoxy}oxane-3,4,5-triol

C31H52O12 (616.3459)

6-[(8a-carboxy-4,4,6a,6b,14b-pentamethyl-11-methylidene-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C35H52O9 (616.3611)

(3e,5e,7e,9e,11e,13e,15z)-18-[(2s,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-1-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

(3s,4ar,6bs,8as,11r,12ar,12bs,14bs)-11-(hydroxymethyl)-4,4,6b,8a,11,12b,14b-heptamethyl-1,2,3,4a,5,7,8,9,10,12,12a,13-dodecahydropicen-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H56O5 (616.4128)

methyl (1r,9r,16r,18r,21s)-6-[(15s,17r,19s)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate

C40H48N4O2 (616.3777)

(2s,3r,4r,5r,6s)-2-{[(2r,3r,4s,5s,6r)-2-{[(2r,3s,3ar,5ar,7s,9ar,9br)-3-hydroxy-2-(3-hydroxyprop-1-en-2-yl)-6,6,9a-trimethyl-decahydro-1h-cyclopenta[a]naphthalen-7-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C31H52O12 (616.3459)

2-[(2-{[5-(2,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl)-3-methylpent-1-en-3-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl)oxy]-6-methyloxane-3,4,5-triol

C32H56O11 (616.3822)

8-(acetyloxy)-2-hydroxy-11-(hydroxymethyl)-2-(2-hydroxypropan-2-yl)-6,14-dimethyl-7-oxotetracyclo[7.5.0.0¹,³.0⁴,⁸]tetradeca-5,10-dien-13-yl tetradecanoate

C36H56O8 (616.3975)

(5s)-3-[(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-3a,3b,6,6,9a-pentamethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-5-(2-methylprop-1-en-1-yl)-5h-furan-2-one

C36H56O8 (616.3975)

(1r,3r,6s,8r,12r,15r,16r,18s)-18-hydroxy-15-[(2r,5r)-5-hydroxy-6-methyl-4-oxohept-6-en-2-yl]-7,7,12,16-tetramethyl-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-14-one

C35H52O9 (616.3611)

{[(4e,8s,9s,10e,12s,13r,14s,16r)-19-{[2-(dimethylamino)ethyl]amino}-3,13-dihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-20,22-dioxo-2-azabicyclo[16.3.1]docosa-1(21),2,4,6,10,18-hexaen-9-yl]oxy}methanimidic acid

C32H48N4O8 (616.3472)

methyl (1r,12r,14r,15e)-12-[(1r,15s,17s,18s)-17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C40H48N4O2 (616.3777)

1-[2,3-dimethyl-5-(2-oxopropyl)oxolan-2-yl]-18-{2-hydroxy-2,6,6-trimethyl-7-oxabicyclo[2.2.1]heptan-1-yl}-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

3,4,3',8'-tetrahydroxy-β,κ-caroten-6'-one

C40H56O5 (616.4128)

{"Ingredient_id": "HBIN007214","Ingredient_name": "3,4,3',8'-tetrahydroxy-\u03b2,\u03ba-caroten-6'-one","Alias": "NA","Ingredient_formula": "C40H56O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21069","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3,4-dihydroxy-3',6'-epoxy-1',2',5',6'7',8'-hexa-hydro-6'-methyl-16'-nor-β, φ-carotene-1',8'-dione

C40H56O5 (616.4128)

{"Ingredient_id": "HBIN007376","Ingredient_name": "3,4-dihydroxy-3',6'-epoxy-1',2',5',6'7',8'-hexa-hydro-6'-methyl-16'-nor-\u03b2, \u03c6-carotene-1',8'-dione","Alias": "NA","Ingredient_formula": "C40H56O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5873","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2r,3r,4s,5r,6r)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[(1s,4s,5r,9s,10s,13r,14s)-14-hydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methoxy}oxane-3,4,5-triol

C31H52O12 (616.3459)

15-[4-(3,3-dimethyloxiran-2-yl)-4-oxobutan-2-yl]-18-hydroxy-7,7,12,16-tetramethyl-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-14-one

C35H52O9 (616.3611)

(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(1r,2s,4s,5s,8r,10s,14r,15r,18s,20r)-18-hydroxy-1,2,8,15,19,19-hexamethylhexacyclo[12.8.0.0²,¹¹.0⁴,⁸.0⁵,¹⁰.0¹⁵,²⁰]docos-11-ene-5-carbonyloxy]oxane-2-carboxylic acid

C35H52O9 (616.3611)

5,6,11,15-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-14-yl pentadeca-2,4-dienoate

C35H52O9 (616.3611)

(2z,4e,6e,8e,10e,12e,14z,16e,18e)-19-[(3r,4s)-3,4-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3-hydroxy-1-[(1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl]-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

9-(but-1-en-1-yl)-13-hydroxy-14-methyl-2-[(3,4,5-trimethoxy-6-methyloxan-2-yl)oxy]-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione

C35H52O9 (616.3611)

11-(hydroxymethyl)-4,4,6b,8a,11,12b,14b-heptamethyl-1,2,3,4a,5,7,8,9,10,12,12a,13-dodecahydropicen-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H56O5 (616.4128)

18-(3,4-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-1-[2,3-dimethyl-5-(2-oxopropyl)oxolan-2-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

1,6,13,17,23,27-hexahydroxy-1,6,12,17,23,28-hexaazacyclotritriaconta-12,27-diene-2,5,16,24-tetrone

C27H48N6O10 (616.3432)

(2z,4e,6e,8e,10e)-19-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene)-3-hydroxy-1-(4-hydroxy-1,2,2-trimethylcyclopentyl)-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

4-{[(4e)-12,13-dihydroxy-2,4,6,8-tetramethyl-3-oxotetracos-4-enoyl]oxy}-2,3,5-trihydroxypentanoic acid

C33H60O10 (616.4186)

(1s,2s)-2-{2-[(2s,3ar,3bs,7as,11br)-9-hydroxy-10-isopropyl-4,4,7a-trimethyl-2h,3ah,3bh,5h,6h,7h,11bh-phenanthro[9,10-d][1,3]dioxol-2-yl]-5-hydroxy-4-isopropylphenyl}-2,6,6-trimethylcyclohexane-1-carbaldehyde

C40H56O5 (616.4128)

(3s,6s,8s,12r,15r,16r)-15-[(2r)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-oxobutan-2-yl]-3-hydroxy-7,7,12,16-tetramethyl-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}tetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),10-dien-14-one

C35H52O9 (616.3611)

2-(5-hydroxy-2-{9-hydroxy-10-isopropyl-4,4,7a-trimethyl-2h,3ah,3bh,5h,6h,7h,11bh-phenanthro[9,10-d][1,3]dioxol-2-yl}-4-isopropylphenyl)-2,6,6-trimethylcyclohexane-1-carbaldehyde

C40H56O5 (616.4128)

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4r,5r,6s)-2-{[(3s)-5-[(1s,2r,4as,6r,8ar)-2,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpent-1-en-3-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C32H56O11 (616.3822)

2-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[14-hydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methoxy}oxane-3,4,5-triol

C31H52O12 (616.3459)

(1s,2r,3s,4r,8s,9s,13s,14r)-8-(acetyloxy)-2-hydroxy-11-(hydroxymethyl)-2-(2-hydroxypropan-2-yl)-6,14-dimethyl-7-oxotetracyclo[7.5.0.0¹,³.0⁴,⁸]tetradeca-5,10-dien-13-yl tetradecanoate

C36H56O8 (616.3975)

(2s,3r,4r,5r,6s)-2-{[(2r,3r,4s,5s,6r)-2-{[(2r,3r,3ar,5ar,7s,9ar,9br)-3-hydroxy-2-(3-hydroxyprop-1-en-2-yl)-6,6,9a-trimethyl-decahydro-1h-cyclopenta[a]naphthalen-7-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C31H52O12 (616.3459)

(1r,5r,7r)-4-hydroxy-3-(4-hydroxy-3-methoxybenzoyl)-8,8-dimethyl-5-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C39H52O6 (616.3764)

(1r,2s,4r,5s,6s,10s,11r,12r,14r,15r)-5,6,11,14-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-15-yl (2e,4e)-pentadeca-2,4-dienoate

C35H52O9 (616.3611)

(3s,6s,9s,12s)-3-benzyl-9-{[4-(buta-2,3-dien-1-yloxy)phenyl]methyl}-5,11-dihydroxy-1,7-dimethyl-6,12-bis(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione

C36H48N4O5 (616.3625)

(13e)-10,11,16-trihydroxy-7,14,15,19-tetramethyl-12-methylidene-2-[(1e)-4-methylpenta-1,3-dien-1-yl]-3,26,27-trioxatricyclo[21.2.1.1⁶,⁹]heptacos-13-ene-4,18,21-trione

C35H52O9 (616.3611)

(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl (1s,3r,6s,7s,8r,11s,12s,15r,16r)-6-hydroxy-7,12,16-trimethyl-15-[(2r)-6-methyl-4-oxohept-5-en-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylate

C36H56O8 (616.3975)

2-[(6-hydroxy-1,4a,6-trimethyl-5-{3-methyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]pent-4-en-1-yl}-hexahydro-2h-naphthalen-1-yl)methoxy]-6-methyloxane-3,4,5-triol

C32H56O11 (616.3822)

(2r,3r,4r,5r,6s)-2-{[(1r,4ar,5s,6r,8as)-6-hydroxy-1,4a,6-trimethyl-5-[(3s)-3-methyl-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}pent-4-en-1-yl]-hexahydro-2h-naphthalen-1-yl]methoxy}-6-methyloxane-3,4,5-triol

C32H56O11 (616.3822)

(6s,11r,12s,13r,15r,16r)-13-hydroxy-15-[(2r)-6-hydroxy-6-methyl-4-oxoheptan-2-yl]-7,7,12,16-tetramethyl-6-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}tetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2,8-trien-14-one

C35H52O9 (616.3611)

(1s,3r,6s,8r,12r,15s,16r,18s)-15-[(2r)-4-[(2s)-3,3-dimethyloxiran-2-yl]-4-oxobutan-2-yl]-18-hydroxy-7,7,12,16-tetramethyl-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-14-one

C35H52O9 (616.3611)

6-{11-hydroxy-7-[(3-methoxy-3-oxopropanoyl)oxy]-3a,6,6,9a,11a-pentamethyl-4-oxo-1h,2h,3h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2,3-dimethyl-4-oxoheptanoic acid

C35H52O9 (616.3611)

(2r,3s,4s,5r,6r)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[(1s,4s,5r,9s,10r,13r,14s)-14-hydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methoxy}oxane-3,4,5-triol

C31H52O12 (616.3459)

2-{[4,5-dihydroxy-2-({5-[2-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpent-1-en-3-yl}oxy)-6-methyloxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C32H56O11 (616.3822)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6ar,6bs,8ar,10s,12as,14bs)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,14b-dodecahydropicene-4a-carboxylate

C36H56O8 (616.3975)

(2s,6r)-6-[(1r,3as,5ar,7r,9as,11s,11ar)-7-{[(3s)-3-carboxy-3-hydroxy-3-methylpropanoyl]oxy}-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C36H56O8 (616.3975)

(4as,9r,10as)-6-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-9-yl (1r,4ar,4br,7r,10ar)-7-ethenyl-1,4a,7-trimethyl-9-oxo-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboperoxoate

C40H56O5 (616.4128)

(2s,4r,5s,6s,10s,11r,12r,14r,15r)-5,6,11,14-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-15-yl (2e,4e)-pentadeca-2,4-dienoate

C35H52O9 (616.3611)

methyl (1r,9r,16s,18r,21s)-6-[(15s,17r,19s)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate

C40H48N4O2 (616.3777)

(3e,5e,7e,9e,11e,13e,15e)-1-[(1e,2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-18-[(2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

13-hydroxy-15-(6-hydroxy-6-methyl-4-oxoheptan-2-yl)-7,7,12,16-tetramethyl-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]tetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2,8-trien-14-one

C35H52O9 (616.3611)

(1r,2s,6r,7s,9r,10s,11r,13e,15r,16s,19s,23s)-10,11,16-trihydroxy-7,14,15,19-tetramethyl-12-methylidene-2-[(1e)-4-methylpenta-1,3-dien-1-yl]-3,26,27-trioxatricyclo[21.2.1.1⁶,⁹]heptacos-13-ene-4,18,21-trione

C35H52O9 (616.3611)

3-benzyl-9-{[4-(buta-2,3-dien-1-yloxy)phenyl]methyl}-5,11-dihydroxy-1,7-dimethyl-6,12-bis(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione

C36H48N4O5 (616.3625)

(2z,4e,6e,8e,10e)-3-hydroxy-1-(4-hydroxy-1,2,2-trimethylcyclopentyl)-19-{2-hydroxy-2,6,6-trimethyl-7-oxabicyclo[2.2.1]heptan-1-yl}-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

(2r,3r,4s,5s,6r)-2-{[(1s,2r,4as,8ar)-1-[(3z)-3-(2-{[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}ethylidene)-4-hydroxybutyl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C31H52O12 (616.3459)

4-hydroxy-3-(4-hydroxy-3-methoxybenzoyl)-8,8-dimethyl-5-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C39H52O6 (616.3764)

(2s,3r,4s,5r)-2-[(1'r,4'r,6'r,12'r,16'r,21'r)-4',5,6',12',17',17'-hexamethyl-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-13'-en-4-oloxy]oxane-3,4,5-triol

C35H52O9 (616.3611)

(3e,5e,7e,9e,11e,13e,15e)-18-[(2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-1-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4r,5r,6s)-2-{[(3s)-5-[(1s,2r,4as,5r,8ar)-2-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpent-1-en-3-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C32H56O11 (616.3822)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2r)-2-[(1r,3ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoate

C36H56O8 (616.3975)

2,8,10,13,18,18-hexamethyl-6-(2-methylprop-1-en-1-yl)-17-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicos-19-en-12-one

C36H56O8 (616.3975)

(2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-carboxy-4,4,6a,6b,14b-pentamethyl-11-methylidene-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C35H52O9 (616.3611)

(1s,2s,4r,6r,8r,9r,10r,13r,14r,17s)-2,8,10,13,18,18-hexamethyl-6-(2-methylprop-1-en-1-yl)-17-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicos-19-en-12-one

C36H56O8 (616.3975)

methyl (1r,9r,16r,18r,21s)-6-[(15r,17s,19r)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate

C40H48N4O2 (616.3777)

(2r,3as,5ar,5bs,9r,13s,14r,16as,16br)-9-[(1e)-but-1-en-1-yl]-13-hydroxy-14-methyl-2-{[(2r,3r,4r,5s,6s)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione

C35H52O9 (616.3611)

(3as,7as)-n-(5-carbamimidamido-1-hydroxypentan-2-yl)-6-hydroxy-1-[(2s)-2-[(1-hydroxyoctylidene)amino]-3-(4-hydroxyphenyl)propanoyl]-octahydroindole-2-carboximidic acid

C32H52N6O6 (616.3948)

(2r)-2-[(1r,2r,3as,3bs,7r,9ar,9br,11ar)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-10-oxo-7-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-5-isopropyl-2-methylfuran-3-one

C35H52O9 (616.3611)

(3e,5e,7e,9e,11e,13e,15e,17e)-1-[(2s,3r,5r)-2,3-dimethyl-5-(2-oxopropyl)oxolan-2-yl]-18-[(1r,2r,4s)-2-hydroxy-2,6,6-trimethyl-7-oxabicyclo[2.2.1]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

6-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-9-yl 7-ethenyl-1,4a,7-trimethyl-9-oxo-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboperoxoate

C40H56O5 (616.4128)

(1s,3r,6s,8r,12r,15r,16r,18s)-15-[(2r)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-oxobutan-2-yl]-18-hydroxy-7,7,12,16-tetramethyl-6-{[(2s,3s,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-14-one

C35H52O9 (616.3611)

(2s,3r,6r)-6-[(1r,3ar,5ar,7r,9as,11r,11ar)-11-hydroxy-7-[(3-methoxy-3-oxopropanoyl)oxy]-3a,6,6,9a,11a-pentamethyl-4-oxo-1h,2h,3h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,3-dimethyl-4-oxoheptanoic acid

C35H52O9 (616.3611)

6-({5-carboxy-1,2,8,15,19,19-hexamethylhexacyclo[12.8.0.0²,¹¹.0⁴,⁸.0⁵,¹⁰.0¹⁵,²⁰]docos-11-en-18-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C35H52O9 (616.3611)

(2r,3r,4s,5s,6r)-2-{[(1s,2r,4as,8ar)-1-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methoxy}-6-({[(2r,3s,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxane-3,4,5-triol

C31H52O12 (616.3459)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-methylhept-5-enoate

C36H56O8 (616.3975)

4-(acetyloxy)-1-[5-(1,2-dihydroxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-10-yl acetate

C35H52O9 (616.3611)

7-hydroxy-3a,6,6,11a-tetramethyl-1-(6-methylhepta-4,6-dien-2-yl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde

C36H56O8 (616.3975)

(3e,5e,7e,9e,11e,13e,15e)-18-[(2r,4r)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-1-[(1s,4r,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

(2s,3as,7as)-n-(5-carbamimidamido-1-hydroxypentan-2-yl)-6-hydroxy-1-[(2s)-2-[(1-hydroxyoctylidene)amino]-3-(4-hydroxyphenyl)propanoyl]-octahydroindole-2-carboximidic acid

C32H52N6O6 (616.3948)

(3e,5e,7e,9e,11e,13e,15e,17e)-18-[(3r,4s)-3,4-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-1-[(2s,3r,5r)-2,3-dimethyl-5-(2-oxopropyl)oxolan-2-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

3,4,5-trihydroxy-6-{18-hydroxy-1,2,8,15,19,19-hexamethylhexacyclo[12.8.0.0²,¹¹.0⁴,⁸.0⁵,¹⁰.0¹⁵,²⁰]docos-11-ene-5-carbonyloxy}oxane-2-carboxylic acid

C35H52O9 (616.3611)

4-{[(4e)-13,14-dihydroxy-2,4,6,8-tetramethyl-3-oxotetracos-4-enoyl]oxy}-2,3,5-trihydroxypentanoic acid

C33H60O10 (616.4186)

(3e,5e,7e,9e)-18-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene)-1-{4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

(1s,4s,5s,6r,9s,10r,12s,14r)-7-[(hexanoyloxy)methyl]-5,6,12-trihydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-4-yl decanoate

C36H56O8 (616.3975)

4-[(13,14-dihydroxy-2,4,6,8-tetramethyl-3-oxotetracos-4-enoyl)oxy]-2,3,5-trihydroxypentanoic acid

C33H60O10 (616.4186)

(1r,3s,11r)-7-(4-hydroxy-3-methoxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C39H52O6 (616.3764)

(2s,3e,5r)-2-(acetyloxy)-10-[(1s,3s,6s)-6-(acetyloxy)-3-hydroxy-2,2,6-trimethylcyclohexyl]-3,8-dimethyl-1-[(1r)-2,6,6-trimethyl-5-oxocyclohex-2-en-1-yl]deca-3,7-dien-5-yl acetate

C36H56O8 (616.3975)

methyl (1r,9s,10r,12r,19r)-12-ethyl-10-[(15s,16s,19s)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-16-yl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-10-carboxylate

C40H48N4O2 (616.3777)

{[(4e,6z,8s,9s,10e,12s,13r,14s,16r)-19-{[2-(dimethylamino)ethyl]amino}-3,13-dihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-20,22-dioxo-2-azabicyclo[16.3.1]docosa-1(21),2,4,6,10,18-hexaen-9-yl]oxy}methanimidic acid

C32H48N4O8 (616.3472)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,14b-dodecahydropicene-4a-carboxylate

C36H56O8 (616.3975)

(2s,3s,4r,5r,6r)-2-({[(2r,3s,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[(1r,4s,5r,9s,10s,13s,14s)-14-hydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methoxy}oxane-3,4,5-triol

C31H52O12 (616.3459)

(3e,5e,7e,9e,11e,13e,15e)-18-[(2s,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-1-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-2-one

C40H56O5 (616.4128)

(2r,3r,4s,5s,6r)-2-{[(1s,2r,4as,8ar)-1-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methoxy}-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxane-3,4,5-triol

C31H52O12 (616.3459)

(1r,4r,7s,9r,11r)-1-benzoyl-11-[(2e,6e)-3,8-dimethylnona-2,6-dien-1-yl]-4-hydroxy-3-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-6,6,13,13-tetramethyl-5-oxatetracyclo[7.3.1.0³,⁷.0⁴,¹¹]tridecane-2,12-dione

C39H52O6 (616.3764)

methyl (12r,15e)-12-[(1r,15s,17s,18s)-17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C40H48N4O2 (616.3777)

(2z,4e,6e,8e,10e)-19-(3,4-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3-hydroxy-1-(4-hydroxy-1,2,2-trimethylcyclopentyl)-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

2-[(4,5-dihydroxy-2-{[3-hydroxy-2-(3-hydroxyprop-1-en-2-yl)-6,6,9a-trimethyl-decahydro-1h-cyclopenta[a]naphthalen-7-yl]oxy}-6-(hydroxymethyl)oxan-3-yl)oxy]-6-methyloxane-3,4,5-triol

C31H52O12 (616.3459)

methyl (1r,9r,16r,18s,21s)-6-[(15r,17s,19r)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate

C40H48N4O2 (616.3777)

(2s)-n-[2-(1-carbamimidoyl-2,5-dihydropyrrol-3-yl)ethyl]-1-(2-{[(2r)-1,2-dihydroxy-3-phenylpropylidene]amino}-3-phenylpropanoyl)-6-hydroxy-octahydroindole-2-carboximidic acid

C34H44N6O5 (616.3373)

(3r,6s,8s,12r,15r,16r)-15-[(2r)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-oxobutan-2-yl]-3-hydroxy-7,7,12,16-tetramethyl-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}tetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),10-dien-14-one

C35H52O9 (616.3611)

4-[(12,13-dihydroxy-2,4,6,8-tetramethyl-3-oxotetracos-4-enoyl)oxy]-2,3,5-trihydroxypentanoic acid

C33H60O10 (616.4186)

methyl 6-{15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl}-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate

C40H48N4O2 (616.3777)

(2z,4e,6e,8e,10e,12e,14e,16e,18e)-3-hydroxy-1-[(1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl]-19-[(1r,2r,4s)-2-hydroxy-2,6,6-trimethyl-7-oxabicyclo[2.2.1]heptan-1-yl]-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one

C40H56O5 (616.4128)

(1r,3s,9r,11r)-7-(4-hydroxy-3-methoxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C39H52O6 (616.3764)

2-({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[2-hydroxy-5-(5-hydroxy-3-methylpent-3-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methoxy}oxane-3,4,5-triol

C31H52O12 (616.3459)

(1r,3as,3bs,4s,7s,9ar,9br,11ar)-7-hydroxy-3a,6,6,11a-tetramethyl-1-[(2r,4e)-6-methylhepta-4,6-dien-2-yl]-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthrene-9b-carbaldehyde

C36H56O8 (616.3975)